Abstract: The present disclosure provides a composition comprising isolated T cells, wherein the T cells have specificity against a range of clinical fungal pathogens.
Type:
Grant
Filed:
July 7, 2016
Date of Patent:
March 9, 2021
Assignees:
The University of Sydney, Western Sydney Local Health District, Westmead Institute for Medical Research, NSW Health Pathology
Inventors:
David Gottlieb, Leighton Clancy, Emily Blyth, Kenneth Paul Micklethwaite, Shivashni Deo